BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  Relay Therapeutics Lands $63M to Push Its Cancer Candidates Into Clinic

  The round was led by BVF Partners, with new investors GV, Casdin Capital, EcoR1 Capital and Section 32.

  December 14, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  It’s Official: Teva Cuts 14,000 Jobs in Massive Reorg

  Teva pulled the trigger on a comprehensive restructuring plan that includes the elimination of 25 percent of the company’s global workforce.

  December 14, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Another Biotech Bites the Dust as Cambridge’s Raze Shuts Down

  As part of a portfolio update, Altas Ventures noted that Raze Therapeutics, a biotech launched in 2014, has closed its doors.

  December 14, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  Boulder Biotech Changes Name, Gives Away New CRISPR Enzyme -- Free of Charge

  In its announcement, Inscripta called the plan a “huge step forward for innovation” in the highly competitive gene-editing field.

  December 14, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioForest

  The Most Affordable CAR-T Biotech Stock Among Its Rivals Right Now

  Juno Therapeutics is now the “cheapest” player now developing CAR-T cancer medications, an analyst said Wednesday as he downgraded rival Bluebird Bio.

  December 14, 2017

   · 

  1 min read
• Policy

  Medtronic Forks Over $12M to Settle Infuse False Marketing Claims

  The Mass. Attorney General said the deal will resolve an investigation by her office and those in four other states related to Medtronic’s promotion of Infuse.

  December 14, 2017

   · 

  1 min read
• 

  Genetown

  AbbVie, Pfizer Jump in on Newly-Launched Jnana Therapeutics’ $50M Funding Round

  Seed funders Polaris Partners and Avalon Ventures were joined in the round by Versant Ventures, AbbVie Ventures and Pfizer R&D Innovate.

  December 14, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Merck’s Ace Keytruda Flunks Key Phase III Stomach Cancer Study

  Merck’s Keytruda came up short in a pivotal Phase III trial as a second-line treatment for patients with advanced gastricadenocarcinoma or GEJ adenocarcinoma.

  December 14, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  The Next Biotech ‘Unicorn,’ Ginkgo Bioworks, Just Nabbed Another $275M

  Ginkgo Bioworks, recently recognized by Forbes as one of 25 U.S. companies likely to hit a valuation of $1B or more, is well on its way.

  December 14, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Pharm Country

  This is the Drug That Could Kick Regeneron’s Stock Into Gear

  Regeneron shares have made little headway since the disappointing launch of Praluent in 2015.

  December 14, 2017

   · 

  1 min read